Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/16/2009 | EP2101170A1 Method, system and computer program for contactless measuring a moisture percentage |
09/16/2009 | EP2100971A2 Real-time sequence determination |
09/16/2009 | EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents |
09/16/2009 | EP2100958A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
09/16/2009 | EP2100931A1 Coating agent for preventing nonspecific adsorption |
09/16/2009 | EP2100903A2 Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII |
09/16/2009 | EP2100899A2 Compounds for proteasome enzyme inhibition |
09/16/2009 | EP2100637A1 Respiratory apparatus with a bioburden indicator |
09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
09/16/2009 | EP2100615A1 Cancer therapy |
09/16/2009 | EP2100560A1 Test sensor with thin lancet |
09/16/2009 | EP2100512A1 Method for controlling ground meat flow rates |
09/16/2009 | EP2100507A1 Substance capable of inhibiting cytokinin signaling |
09/16/2009 | EP2100148A2 Method for measuring the concentration of activated factor vii (fviia) in a sample |
09/16/2009 | EP2100147A1 Chemical indicator test strip |
09/16/2009 | EP2100145A2 Diagnosis and risk stratification of cardiac insufficiency using neurophysin |
09/16/2009 | EP2100144A1 Biochemical reaction cassette |
09/16/2009 | EP2100143A1 Coating for microcarriers |
09/16/2009 | EP2100142A1 Composition, device and associated method |
09/16/2009 | EP2100141A1 Saturation assay |
09/16/2009 | EP2100140A2 Methods for treating and diagnosing fibrotic and fibroproliferative diseases |
09/16/2009 | EP2100139A2 Biologically active compositions, methods for producing the same and biological applications |
09/16/2009 | EP2100138A2 Method and system for internal standardization of assays |
09/16/2009 | EP2100130A1 Method of detection of bioanalytes by acousto-mechanical detection systems comprising the addition of liposomes |
09/16/2009 | EP2100129A1 Sensor device |
09/16/2009 | EP2100122A2 Poly (ethylene glycol) anti-body detection assays and kits for performing thereof |
09/16/2009 | EP2100030A2 Spark advance adjustment |
09/16/2009 | EP2099933A2 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
09/16/2009 | EP2099926A1 Modified glass fibers with monolayers of aminocalixarene derivatives and iminecalixarene derivatives, and oligo-dna modified glass fibers by fixing oligo-dna's to the monolayers, and the preparation method of genotyping strips using the oligo-dna modified glass fibers |
09/16/2009 | EP2099925A2 Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system |
09/16/2009 | EP2099920A1 Transgenic mice expressing humanized vegf |
09/16/2009 | EP2099913A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
09/16/2009 | EP2099825A2 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
09/16/2009 | EP2099824A2 Enterococcus faecalis and/or enterococcus faecium antigen |
09/16/2009 | EP2099821A2 Novel genes and proteins that home to developing microvessels |
09/16/2009 | EP2099816A1 Oxocarbonamide peptide nucleic acids and methods of using same |
09/16/2009 | EP2099807A2 Oxidation resistant indicator molecules |
09/16/2009 | EP2099566A2 Sample preparation device |
09/16/2009 | EP2099491A2 Compositions and methods for diagnosing and treating cancer |
09/16/2009 | EP2099410A2 Compositions comprising macromolecular assemblies of lipid and surfactant |
09/16/2009 | EP1904847B1 Saccharide fluorescent substrates, preparation method and uses thereof |
09/16/2009 | EP1853163B1 Breath test for total organic carbon |
09/16/2009 | EP1789192B1 Analytical test element |
09/16/2009 | EP1787127B1 Molecular diagnostic method and treatment in dementia with lewy bodies |
09/16/2009 | EP1776587B9 Use of c3a and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma ; diagnosis methods and assays using the same |
09/16/2009 | EP1704507B1 Methods and system for the identification and charcterization of peptides and their functional relationships by use of measures of correlation |
09/16/2009 | EP1642969B1 Fluorescent protein and pigment protein |
09/16/2009 | EP1639125B1 Fluorescence assay for mtp activity |
09/16/2009 | EP1638599B1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
09/16/2009 | EP1625395B1 Method for identifying tff2 regulating agents |
09/16/2009 | EP1539994B1 Method of monitoring biofouling in membrane separation systems |
09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
09/16/2009 | EP1472541B1 Imaging agents and methods of imaging naaladase of psma |
09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
09/16/2009 | EP1438420B1 Methods of using quantitative lipid metabolome data |
09/16/2009 | EP1437338B1 Luminous compounds and labeling reagents using the same |
09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
09/16/2009 | EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses |
09/16/2009 | EP1309720B1 Apparatus and method for detecting and classifying chemicals, particles, viruses, and bacteria in fluids with an aptamer |
09/16/2009 | EP1278891B1 Method and probes for the genetic diagnosis of hemochromatosis |
09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
09/16/2009 | EP1226404B1 Methods and apparatus for determining the location of a shaft within a vessel |
09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
09/16/2009 | EP1093462B1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
09/16/2009 | EP1051618B1 Method and apparatus for determining blood oxygen transport |
09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
09/16/2009 | EP0946818B2 Method and device for process control during bleaching of fibrous materials |
09/16/2009 | CN201311420Y Saliva test pen |
09/16/2009 | CN201311419Y Measurer of supplying water amount |
09/16/2009 | CN201311418Y Integrated monitoring system of water quality abrupt change |
09/16/2009 | CN201311417Y Biological behavior index monitoring system of water quality abrupt change |
09/16/2009 | CN201311416Y Underground gas desorption rate tester |
09/16/2009 | CN101535814A Standard/reference/control for blood coagulation testing |
09/16/2009 | CN101535813A Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization |
09/16/2009 | CN101535812A Analysis of proteolytic processing by mass spectrometry |
09/16/2009 | CN101535811A Method for in vitro diagnosis of PVL-producing staphylococcus aureus |
09/16/2009 | CN101535810A Diagnosis of fasciolosis by skin test (intradermoreaction) using the antigen Fh8 (fasciolin) |
09/16/2009 | CN101535809A A device for, an arrangement for and a method of analysing a sample |
09/16/2009 | CN101535808A Method for the purification of at least one target substance that is to be identified |
09/16/2009 | CN101535807A Methods and kits for detecting cerebrospinal fluid in a sample |
09/16/2009 | CN101535806A Porous biological assay substrate and method and device for producing such substrate |
09/16/2009 | CN101535805A Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components |
09/16/2009 | CN101535804A Hematology linearity control composition system and method of use |
09/16/2009 | CN101535803A Apparatus for gelation measurement and sample cell |
09/16/2009 | CN101535802A Design and selection of genetic targets for sequence resolved organism detection and identification |
09/16/2009 | CN101533030A Quality control method for the noninvasive screening of biochemical indicators during early pregnancy |
09/16/2009 | CN101533029A Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
09/16/2009 | CN101533028A Chemoluminescent immunoassay kit of hyaluronic acid and preparation method thereof |
09/16/2009 | CN101533027A Biosensing technology for detecting interaction of small molecules and binding protein based on protection and analysis of terminals of single-stranded exonuclease |
09/16/2009 | CN101533026A Chemoluminescent immunoassay kit of hepatitis A virus IgG antibody and preparation method thereof |
09/16/2009 | CN101533025A Chemoluminescent immunoassay kit of hepatitis A virus IgM antibody and preparation method thereof |
09/16/2009 | CN101533024A Application of Yersinia pestis Caf1M protein |
09/16/2009 | CN101533023A New method and product for detecting avian influenza antibody in serum sample |
09/16/2009 | CN101533022A New method and product for detecting influenza antibody in serum sample |
09/16/2009 | CN101533021A New method and product for detecting tuberculosis antibody in serum sample |
09/16/2009 | CN101533020A New method for detecting SARS antibody in serum sample and a product thereof |
09/16/2009 | CN101533019A New method for detecting plague antibodies in serum sample and product thereof |
09/16/2009 | CN101533018A Detection kit for distinguishing cow pathogenic mycobacteria infection from non-pathogenic mycobacteria infection and method thereof |
09/16/2009 | CN101533017A Mycobacterium bovis infection detection kit meditated by recombined fusion protein and method thereof |